Details for New Drug Application (NDA): 016909
✉ Email this page to a colleague
The generic ingredient in LIDEX is fluocinonide. There are nine drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.
Summary for 016909
Tradename: | LIDEX |
Applicant: | Alvogen |
Ingredient: | fluocinonide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016909
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 016909
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alvogen | LIDEX | fluocinonide | OINTMENT;TOPICAL | 016909-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription